Advertisements


We are Sorry, This Page doesn't Exist


The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»

Category: blogSource: benzingaFeb 6th, 2021

World shares mixed amid hopes for business pickup, weak data; oil slides

World equity markets were mixed on Wednesday, with U.S. indexes seesawing amid hopes for a pickup in business activity and as oil prices slumped with demand low after a rise in U.S. crude stockpiles last week to three-year highs......»»

Category: topSource: reutersMay 6th, 2020

Shares shuffle higher, dollar lays low ahead of U.S. jobs data

World shares were eyeing two-year highs and a fourth straight week of gains on Friday as the third U.S. interest rate cut of the year and a surprise bounce in Chinese manufacturing activity eclipsed a blizzard of otherwise sickly global data......»»

Category: topSource: reutersNov 1st, 2019

Aircraft Order Pause Continues Ahead of the Paris Air Show

Airbus NASDAQOTH EADSY and to a lesser extent Boeing NYSE BA may be preparing to reveal a slew of new aircraft orders at next week s Paris Air Show However so far 2019 has been an extremely quiet year in terms of order activity This order slump continued.....»»

Category: futuresSource: nasdaqJun 13th, 2019

U.S. IPO Week Ahead: Pinterest And Zoom Headline Year"s Busiest Week With 8 IPOs

U.S. IPO Week Ahead: Pinterest And Zoom Headline Year"s Busiest Week With 8 IPOs.....»»

Category: topSource: seekingalphaApr 13th, 2019

US IPO Week Ahead: Pinterest and Zoom headline year"s busiest week with 8 IPOs

A whopping eight IPOs plan.....»»

Category: futuresSource: nasdaqApr 13th, 2019

U.S. IPO Week Ahead: Online Training Course Unicorn Pluralsight Leads 3 IPO Week

U.S. IPO Week Ahead: Online Training Course Unicorn Pluralsight Leads 3 IPO Week.....»»

Category: topSource: seekingalphaMay 12th, 2018

IPO News This Week: Tech Unicorn Pluralsight Highlights 3 Offerings

There are three IPOs on the calendar for the coming week seeking to raise more than $700 million. For the year to date, proceeds for all IPOs are at their highest level since 2008......»»

Category: blogSource: 247wallstMay 13th, 2018

U.S. IPO Week Ahead: 12 IPOs Scheduled For The Busiest Week Of The Year

U.S. IPO Week Ahead: 12 IPOs Scheduled For The Busiest Week Of The Year.....»»

Category: topSource: seekingalphaJun 23rd, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs And More

A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. Here's a look at the upcoming week's catalytic events. read more.....»»

Category: blogSource: benzingaJul 14th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs And More

A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. He.....»»

Category: earningsSource: benzingaJul 14th, 2018

IPO News This Week: 8 Firms Looking to Capital Markets for $3.26 Billion

Five IPOs raised $1.33 billion last week. In the week ahead, eight companies are seeking a total of $3.26 billion in the IPO market. More new capital has been raised to date this year than in all of........»»

Category: blogSource: 247wallstSep 16th, 2018

The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech were trending mostly sideways in the week ending Sept. 14 after posting weekly gains in the previous two weeks. Notwithstanding the overall muted sentiment, there was some activity in reaction to the release of clinical trial results. read more.....»»

Category: blogSource: benzingaSep 16th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs

As we step into the final quarter of 2018, biotech stocks have recorded double-digit gains for the year-to-date period. Will the run up continue? Stay tuned to the following events of the upcoming week. read more.....»»

Category: blogSource: benzingaOct 8th, 2018

The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs

Large-cap pharma stocks are seeing some upward momentum and are on track to finish the year with handsome gains. As the year draws to a close, it remains to be see.....»»

Category: personnelSource: nytDec 2nd, 2018

Topgolf Recovering Ahead Of Plan, Callaway Capitalizing On Golf Demand

Shares of golf equipment manufacturer and Topgolf owner Callaway Golf Company (NYSE: ELY) hit new 52-week highs Tuesday after reporting first-quarter earnings. The company saw revenue at $651 million, up 47% year-over-year and w.....»»

Category: smallbizSource: nytMay 11th, 2021

The Major US Indexes Close Higher for the Week

Dow Jones leads year to date gains with a return of 11.78%Related Stocks: MS, MRNA, PFE, TSLA, JNJ,.....»»

Category: dealsSource: nytApr 17th, 2021

The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs

Biotech stocks reversed course in the week ended April 16, with the sector re.....»»

Category: blogSource: benzingaApr 17th, 2021

Goldman, JPM Expect Econ Activity In April, May To Top "Anything We"ll See In Our Careers"

Goldman, JPM Expect Econ Activity In April, May To Top "Anything We'll See In Our Careers" Last week, ahead of both the March payrolls and a burst of closely watched economic data in t.....»»

Category: smallbizSource: nytApr 4th, 2021

Local market exec at Regions Financial on pandemic adjustments and what"s ahead this year

CBJ spoke with Tim Monte, Charlotte market executive at Regions Financial, this week about how the bank has handled an uncertain environment and what he sees as the next steps in 2021......»»

Category: topSource: bizjournalsApr 1st, 2021